Abaxis (ABAX) Soars: Stock Rises 9% - Tale of the Tape

by Zacks, Benzinga Contributor
July 28, 2014 4:55 PM | 2 min read |
Abaxis, Inc. ABAX was a big mover last session, as its shares rose roughly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up almost 10% in the past one-month timeframe.

In the last 30 days, the company witnessed three positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday's jump can turn into more strength down the road.

Abaxis currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Other well-performing stocks in the med-products industry include Alere Inc. ALR, Boston Scientific Corporation BSX and Cardiovascular Systems Inc. CSII. All three carry the same Zacks Rank as Abaxis.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ABAXIS INC ABAX: Free Stock Analysis Report
 
CARDIOVASCLR SY CSII: Free Stock Analysis Report
 
ALERE INC ALR: Free Stock Analysis Report
 
BOSTON SCIENTIF BSX: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Movers & ShakersGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!